0000899243-20-000995.txt : 20200110 0000899243-20-000995.hdr.sgml : 20200110 20200110181416 ACCESSION NUMBER: 0000899243-20-000995 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200108 FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McDonough John CENTRAL INDEX KEY: 0001615937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 20522147 MAIL ADDRESS: STREET 1: T2 BIOSYSTEMS, INC. STREET 2: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-08 0 0001492674 T2 Biosystems, Inc. TTOO 0001615937 McDonough John 101 HARTWELL AVE LEXINGTON MA 02421 1 0 0 0 Common Stock 2020-01-08 4 M 0 16666 A 470285 D Common Stock 2020-01-08 4 M 0 100000 A 570285 D Performance Restricted Stock Units 2020-01-08 4 D 0 326087 0.00 D Common Stock 326087 0 D Restricted Stock Units 2020-01-08 4 M 0 16666 0.00 D Common Stock 16666 0 D Restricted Stock Units 2020-01-08 4 M 0 100000 0.00 D Common Stock 100000 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Includes 5,399 shares acquired under the Issuer's employee stock purchase plan on May 15, 2019. On March 15, 2018, the reporting person was granted Performance Restricted Stock Units that vest in the form of common stock based upon the achievement of certain pre-established 90-day average daily closing prices per share goals over a three year performance period. On January 8, 2020, the reporting person incurred a termination of service and forfeited the remaining unvested RSU's subject to this grant. Pursuant to the terms of that certain Employment Agreement by and between the reporting person and Issuer, dated March 4, 2008, as amended by that certain First Amendment to Employment Agreement, dated July 7, 2014 and that certain Second Amendment to Employment Agreement, dated July 30, 2019, upon the reporting person's resignation as Chief Executive Officer, these RSUs automatically vested on January 8, 2020. /s/ John Sprague, Attorney-in-fact 2020-01-10